Jue Pu
Director/Miembro de la Junta en LEPU BIOPHARMA CO., LTD. .
Fortuna: 63 M $ al 30/04/2024
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Eric Rowinsky | M | 67 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 9 años |
Ambaw Bellete | M | 54 | 1 años | |
De Min Zhou | M | 58 | 4 años | |
Ziye Sui | M | - | 4 años | |
Saeed Tavazoie | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 14 años |
Yun Yi Li | F | 44 | 4 años | |
Hai Feng Yang | M | 47 | 4 años | |
Victor Tong | M | 41 | 1 años | |
Zhong Jie Pu | M | 61 | 6 años | |
Feng Mao Hua | M | 56 | 3 años | |
Brian Liu | M | 36 | 2 años | |
David Mangelsdorf | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | - |
peter vlasselaer | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 6 años |
Maggie Geman Li | F | 58 | 4 años | |
Hu Li | M | 59 | 4 años | |
Lei Fang | M | 41 | 4 años | |
Vijay Kasturi | M | 57 | 1 años | |
Min MIn Qin | M | 66 | 4 años | |
Tess Hau | F | - |
Stanford University
| 12 años |
Raymond Camahort | M | 45 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 3 años |
Hongbing Yang | M | 55 | 4 años | |
Jiwei Wang | M | 37 | 4 años | |
Nancy T. Chang | M | 74 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | - |
Ming Yang | M | 58 | 4 años | |
Dieter Weinand | M | 63 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 3 años |
Siu Kuen Lai | F | 48 | 3 años | |
Nilesh Kumar | M | 47 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | - |
Yang Xu | M | 57 | 4 años | |
Usman Azam | M | 55 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 1 años |
Peter van Vlasselaer | M | 64 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 6 años |
Antoine Papiernik | M | 56 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | - |
Swapnil Bhargava | M | - | 1 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Masoud Tavazoie | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 13 años |
Peter Moran | M | - |
Stanford University
| 4 años |
Yi Peng Li | M | 47 | - | |
Raakhe Kapoor Tandon | F | - |
The Wharton School of the University of Pennsylvania
| 5 años |
Eli Simon | M | - |
The Wharton School of the University of Pennsylvania
| 5 años |
Greg Kress | M | - |
Stanford University
| 5 años |
Haomiao Huang | M | - |
Stanford University
| 7 años |
Pranav Gupta | M | - |
The Wharton School of the University of Pennsylvania
| 13 años |
Neel Murthy | M | - |
Stanford University
| 6 años |
Steven Finn | M | 38 |
The Wharton School of the University of Pennsylvania
| 4 años |
Kristen Wong | F | - |
Stanford University
| 4 años |
Sydney Werber | F | - |
The Wharton School of the University of Pennsylvania
| 4 años |
Chao Hong Hu | M | 58 | 4 años | |
Xiaohan Zhu | M | - |
The Wharton School of the University of Pennsylvania
| 2 años |
Edward Segal | M | - |
Stanford University
| 4 años |
Eric Sun | M | - |
The Wharton School of the University of Pennsylvania
| 11 años |
Christine Black | F | - |
The Wharton School of the University of Pennsylvania
| 10 años |
Jing Lin | F | - |
The Wharton School of the University of Pennsylvania
| 8 años |
Jennifer Rowland | F | - |
The Wharton School of the University of Pennsylvania
| 5 años |
Emily Janvey | M | - |
The Wharton School of the University of Pennsylvania
| 5 años |
Sapna Tejwani Jethwa | F | - |
The Wharton School of the University of Pennsylvania
| 11 años |
Steven Kozhimala | M | - |
The Wharton School of the University of Pennsylvania
| 10 años |
Jordan Moelis | M | - |
The Wharton School of the University of Pennsylvania
| 5 años |
Samir Malik | M | - |
The Wharton School of the University of Pennsylvania
| 7 años |
Stewart Lynn | M | - |
Stanford University
| 5 años |
Shirin Bohra | F | - |
The Wharton School of the University of Pennsylvania
| 12 años |
Chase Beeler | M | - |
Stanford University
| 5 años |
Zavain Dar | M | 35 |
Stanford University
| 6 años |
David Bard | M | - |
The Wharton School of the University of Pennsylvania
| 12 años |
Vandit D. Shah | M | - |
The Wharton School of the University of Pennsylvania
| 3 años |
Samir Siddhanti | M | - |
Stanford University
| 5 años |
Rama Sekhar | M | - |
The Wharton School of the University of Pennsylvania
| 2 años |
Sahil Bloom | M | - |
Stanford University
| 4 años |
Rashad Rahman | M | - |
The Wharton School of the University of Pennsylvania
| 15 años |
Justin Green | M | - |
The Wharton School of the University of Pennsylvania
| 11 años |
Gabriel Luft | M | - |
The Wharton School of the University of Pennsylvania
| 2 años |
Scott A. Freishtat | M | - |
The Wharton School of the University of Pennsylvania
| 2 años |
Dustin Price | M | - |
The Wharton School of the University of Pennsylvania
| 3 años |
Adam Levinson | M | - |
The Wharton School of the University of Pennsylvania
| 4 años |
Ben Herman | M | - |
The Wharton School of the University of Pennsylvania
| 2 años |
Albert Kim | M | - |
The Wharton School of the University of Pennsylvania
| 4 años |
Rachel Fleszar | F | - |
The Wharton School of the University of Pennsylvania
| 4 años |
Tomohiro Ishii | M | 50 |
The Wharton School of the University of Pennsylvania
| 2 años |
Albert Centena | M | 40 |
The Wharton School of the University of Pennsylvania
| 2 años |
Ahmad Bader Ahmad Wahedi | M | - |
The Wharton School of the University of Pennsylvania
| 2 años |
Jeannette Donkervoet | F | - |
The Wharton School of the University of Pennsylvania
| 4 años |
Sandeep Mirani | M | - |
The Wharton School of the University of Pennsylvania
| 4 años |
Jason deFaria | M | - |
The Wharton School of the University of Pennsylvania
| 4 años |
Anu Hariharan | F | 43 |
The Wharton School of the University of Pennsylvania
| 2 años |
Jamie Roberts Seltzer | M | 35 |
The Wharton School of the University of Pennsylvania
| 4 años |
Arjun Mohan | M | - |
The Wharton School of the University of Pennsylvania
| 2 años |
Jagan Pisharath | M | - |
The Wharton School of the University of Pennsylvania
| 2 años |
Ishay Levin | M | - |
The Wharton School of the University of Pennsylvania
| 2 años |
Stephen Carroll | M | - |
The Wharton School of the University of Pennsylvania
| 4 años |
Aaron Zhang | M | - |
The Wharton School of the University of Pennsylvania
| 4 años |
Edward Lando | M | 30 |
The Wharton School of the University of Pennsylvania
| 4 años |
Fay Bou | M | - |
The Wharton School of the University of Pennsylvania
| 2 años |
Alexander Amezquita | M | 51 |
The Wharton School of the University of Pennsylvania
| 2 años |
Kathie Baugh | F | - |
The Wharton School of the University of Pennsylvania
| 2 años |
Eddie Douglas | M | - |
The Wharton School of the University of Pennsylvania
| 2 años |
Jason Hooks | M | - |
The Wharton School of the University of Pennsylvania
| 2 años |
Sean Hong | M | - |
The Wharton School of the University of Pennsylvania
| 6 años |
Mitchell H. Green | M | 42 |
The Wharton School of the University of Pennsylvania
| 2 años |
Neeka Choobineh | F | - |
The Wharton School of the University of Pennsylvania
| 4 años |
Jon Saelinger | M | - |
The Wharton School of the University of Pennsylvania
| 4 años |
Samuel Lerer | M | - |
The Wharton School of the University of Pennsylvania
| 4 años |
Gavin Haladay | M | - |
The Wharton School of the University of Pennsylvania
| 4 años |
Manning Feng | M | - |
The Wharton School of the University of Pennsylvania
| 4 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 83 | 83.00% |
China | 17 | 17.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Jue Pu
- Red Personal